Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis (Q40191493)

18 September 2017

Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis (English)

1 reference

18 September 2017

Irene Noguera-Troise

1

1 reference

18 September 2017

Christopher Daly

2

1 reference

18 September 2017

Nicholas J Papadopoulos

3

1 reference

18 September 2017

Sandra Coetzee

4

1 reference

18 September 2017

Pat Boland

5

1 reference

18 September 2017

Nicholas W Gale

6

1 reference

18 September 2017

Hsin Chieh Lin

7

1 reference

18 September 2017

George D Yancopoulos

8

1 reference

18 September 2017

Gavin Thurston

9

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

18 September 2017

1 reference

18 September 2017

444

1 reference

18 September 2017

1032-1037

1 reference

18 September 2017

7122

1 reference

https://scigraph.springernature.com/pub.10.1038/nature05355

18 September 2017

0 references

cites work

Vascular endothelial growth factor as a target for anticancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene- based discovery of the next generation of angiogenesis targets

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Angiogenesis in life, disease and medicine

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Notch function in the vasculature: insights from zebrafish, mouse and man.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Notch signaling: cell fate control and signal integration in development

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Notch signaling during vascular development

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Dosage-sensitive requirement for mouse Dll4 in artery development

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

A secreted Delta1-Fc fusion protein functions both as an activator and inhibitor of Notch1 signaling

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

HES and HERP families: multiple effectors of the Notch signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Notch signaling in primary endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

The role of notch in modeling and maintaining the vasculature

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Nrarp is a novel intracellular component of the Notch signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

The Nrarp gene encodes an ankyrin-repeat protein that is transcriptionally regulated by the notch signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

High-throughput engineering of the mouse genome coupled with high-resolution expression analysis

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05355

7 January 2021

Identifiers

DOI

10.1038/NATURE05355

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference